Proteonomix Net Income From Continuing Ops from 2010 to 2026
| PROT Stock | USD 0.0001 0.00 0.000003% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -1.6 M | Current Value -1.7 M | Quarterly Volatility 866.1 K |
Check Proteonomix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Proteonomix's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 655.1 K, as well as many indicators such as Price To Sales Ratio of 10.47, Dividend Yield of 0.0 or Days Sales Outstanding of 275. Proteonomix financial statements analysis is a perfect complement when working with Proteonomix Valuation or Volatility modules.
Proteonomix | Net Income From Continuing Ops | Build AI portfolio with Proteonomix Stock |
The evolution of Net Income From Continuing Ops for Proteonomix provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Proteonomix compares to historical norms and industry peers.
Latest Proteonomix's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Proteonomix over the last few years. It is Proteonomix's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Proteonomix's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Proteonomix Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (1,623,865) | |
| Coefficient Of Variation | (53.34) | |
| Mean Deviation | 399,141 | |
| Median | (1,383,846) | |
| Standard Deviation | 866,121 | |
| Sample Variance | 750.2B | |
| Range | 3.6M | |
| R-Value | 0.36 | |
| Mean Square Error | 698.6B | |
| R-Squared | 0.13 | |
| Significance | 0.16 | |
| Slope | 61,114 | |
| Total Sum of Squares | 12T |
Proteonomix Net Income From Continuing Ops History
About Proteonomix Financial Statements
Proteonomix shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Proteonomix investors may analyze each financial statement separately, they are all interrelated. The changes in Proteonomix's assets and liabilities, for example, are also reflected in the revenues and expenses on on Proteonomix's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -1.6 M | -1.7 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Proteonomix Stock Analysis
When running Proteonomix's price analysis, check to measure Proteonomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteonomix is operating at the current time. Most of Proteonomix's value examination focuses on studying past and present price action to predict the probability of Proteonomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteonomix's price. Additionally, you may evaluate how the addition of Proteonomix to your portfolios can decrease your overall portfolio volatility.